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INTRODUCTION: We report a rare case of duodenal metastasis from primary lung adenocarcinoma pre-
sented with history of melena and weight loss.
PRESENTATION OF CASE: A 52-year-old smoker man presented with six months history of epigastric pain,
melena andweight loss. Esophago-gastroduodenoscopy revealed a 10mmulcerative lesion in the fourth
part of duodenum. Histopathology of resected lesion showed poorly differentiated adenocarcinoma.
Tumor cells showed immunopositivity for cytokeratin-7 (CK7), thyroid transcription factor 1 (TTF-1), and
immunonegativity for CK20, Villin, CDX2 and thyroglobulin, supporting the diagnosis of metastatic ade-
nocarcinoma of the lung origin. Computed tomography (CT) of chest revealed left hilarmass encasing the
main pulmonary artery associatedwith ipsilateral hilar and contralateralmediastinal lymphadenopathy.
Bronchoscopy assisted biopsy of lung mass conﬁrmed the diagnosis of primary adenocarcinoma. Patient
was staged as T4N3M1. After the resection of duodenalmetastasis followed by three cycles of cisplatinum
based chemotherapy with Bevacizumab, melena resolved completely.
DISCUSSION:Duodenal metastases from lung adenocarcinoma are extremely uncommon, and rarely pro-
duce symptoms. Most of cases require duodenectomy or pancreatico-duodenectomy for symptomatic
relief. For smaller duodenal metastatic lesions (≤1 cm) endoscopic resection is a feasible therapeutic
option.
CONCLUSION: Although rare, duodenal metastasis from lung adenocarcinoma should also be included
in the differential diagnosis of melena. Smaller lesions (≤1 cm) can safely be managed with endoscopic
resection.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Small bowel as initial site of distant metastasis is relatively rare
clinical entity, and mostly has been reported with colon, uterus,
cervix, ovaries, and breast malignancies [1]. Distant metastases
fromlungcancer areusually found in theadrenal glands, bone, liver,
and brain; however, metastasis in the small bowel is extremely
uncommon [2]. Among small bowel metastasis, the jejunum is
the most frequent site of involvement (50.9%), followed by the
ileum (33.3%), and the duodenum (15.8%) [3]. Duodenal metas-
tases rarely show any symptoms; however, duodenal involvement
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of lung cancer can elicit melena, hypochromic microcytic anemia,
upper gastrointestinal (GI) bleeding, malabsorption, intussuscep-
tion and obstruction [4,5].
Herein we report our experience with a case of melena and
weight loss secondary to metastatic lung adenocarcinoma at the
time of presentation.
2. Presentation of case
A 52-year-old Syrian male patient presented with the six
months history of epigastric pain and melena. He also complained
of anorexia, lethargy, and weight loss of 4 kilograms over past four
months. Epigastric pain was dull in nature, aggravated by food
intake, and it had increased in intensity over two weeks, for which
he was taking oxycodone/acetaminophen, but minimal pain relief.
His previous medical and surgical history was unremarkable. He
was active smoker with one pack a day for 15 years; however, he
denied any alcohol consumption.
http://dx.doi.org/10.1016/j.ijscr.2015.06.019
2210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Esophagastroduodenoscopy showing an ulcerative lesion in the fourth part
of duodenum with no active bleeding.
Fig. 2. Biopsy of duodenal lesion showing neoplasm forming glandular and cords
pattern with frequent mitoses (H & E stain, 400× magniﬁcations).
On physical examination, he was found in good general condi-
tion, and his vitals were stable. On abdominal examination, there
was mild epigastric tenderness without any rigidity, guarding, or
rebound tenderness. The rest of systemic examination was unre-
markable.
Complete blood count (CBC) showedhemoglobin (Hb) 8.4 gm/dl
↓; mean corpuscular volume (MCV) 75 femtoliters (fL) ↓; mean
corpuscular hemoglobin (MCH) 24 picograms (pg)↓, white blood
cells (WBC) 7400/l; red blood cells (RBCs) 4×106/l; and
platelets 356.000/l. Liver and renal function tests were within
normal limits. Fecal occult blood (FOB) test was found posi-
tive. Two units of packed RBCs were transfused to the patient
before elective esophago-gastroduodenoscopy and colonoscopy.
Esophago-gastroduodenoscopy revealed a 10mmulcerative lesion
in the fourth part of duodenum with no bleeding, which was
resected with cold forceps (Fig. 1). The examination of esopha-
gus, stomach and gastroesophageal junction appeared normal, and
colonoscopy was also unremarkable. Histopathology of resected
duodenal lesion showed duodenal mucosal ulceration beneath of
which there was subepithelial tumor inﬁltration, and necrosis.
The neoplasm had nests, cords and single cell growth pattern
in addition to glandular formations. Tumor cells were polygo-
nal shaped with high nuclear/cytoplasmic ratio. There was also
marked nuclear pleomorphism and frequent mitoses (Fig. 2). The
Fig. 3. Biopsied duodenal lesion showing CK7 immunopositive tumor cells (CK7
immunostain, 400× magniﬁcations) suggestingmetastatic adenocarcinoma of lung
origin.
overall picture was that of poorly differentiated adenocarcinoma.
Immunohistochemical analysis showed that the tumour was posi-
tive for cytokeratin-7 (CK7), thyroid transcription factor 1 (TTF-1),
andnegative for CK20, Villin, CDX2and thyroglobulin (Fig. 3). These
ﬁndings strongly supported the diagnosis of metastatic adenocar-
cinoma of the lung origin.
Computed tomography (CT) of chest showed ill-deﬁnednecrotic
massmeasuring4×3.2 cm in left hilar region involvingandextend-
ing to the anterior segment of left upper lobe. The mass was
encasing the leftmain pulmonary artery, alongwith ipsilateral hilar
and contra-lateral para-tracheal, peri-carinal, sub-carinal and hilar
lymphnodes (Fig. 4A). CT abdomenwas unremarkable. CT-positron
emission tomography (CT-PET) showed 18ﬂouro-deoxyglucose
(FDG) avid left upper lobe elongated lung mass [standardized
uptake volume (SUVmax) 9.3] extending from the left hilum to the
pleural surface in the left apical region. There were also FDG avid
right upper paratracheal (SUVmax 4.9), left hilar (SUVmax 4.7), and
subcarinal (SUVmax 6.6) lymph nodes (Fig. 4B). The rest of staging
work upwas negative. Bronchoscopy assisted biopsy of lung lesion
conﬁrmed the diagnosis of primary adenocarcinomawith negative
epidermal growth factor receptor mutation (EGFR-). Patient was
staged as T4N3M1.
After discussing the case in a multidisciplinary tumor board
meeting, patient was started on cisplatinum based chemotherapy
with Bevacizumab. After three cycles of chemotherapy, melena
resolved completely; however, he developedmultiple brainmetas-
tases. After the completionofwhole brain radiation therapy, hewas
started on oral continuous daily dose of 150mg Erlotinib.
3. Discussion
Duodenal involvement as delayed site of distant metastasis or
as initial manifestation of primary lung carcinoma is extremely
rare. Signs and symptoms depend on the anatomic site of duodenal
involvement Table 1 [6–16].
Duodenal metastasis poses a diagnostic dilemma, as radiologic
imaging is often unremarkable as seen our patient. Endoscopic
evaluation and biopsy should be performed in such cases to estab-
lish a deﬁnitive diagnosis especially if the cause of melena or
microcytic anemia cannot be ascertained [6]. Endoscopic ultra-
sonography (EUS) may be helpful for localization of submuscoal
duodenal metastasis in some cases [5–7].
The treatment of duodenal metastasis is also challenging, and
it depends on the site of duodenal involvement and size of
these lesions. However, most of cases require duodenectomy or
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Table 1
Previously published case reports of duodenal metastasis from primary lung carcinoma.
Reference Age
(years)/sex
Symptoms Time of diagnosis Location Histopathology Treatment Follow-up Status
[16] 63/M Melena,
microcytic
anemia
24 months after
treatment for primary
lung cancer
3rd part of
duodenum
Squamous cell carcinoma Duodenectomy 5 months Dead with
progressive
disease
[12] 66/M Perforation During chemoradiation
for primary lung cancer
4th part of
duodenum
Squamous cell carcinoma Duodenectomy followed by
chemotherapy
– –
[14] 75/M Melena,
microcytic
anemia,
intussusception
At time of diagnosis of
primary lung cancer
2nd and 3rd parts
of duodenum
Small cell carcinoma Pancreaticoduodenectomy – –
[6] 58/M Obstruction 2 years after treatment
for primary lung cancer
2nd part of
duodenum
Large cell carcinoma Pancreatico-duodenectomy
followed by chemotherapy
46 months Alive disease free
[7] 46/F Melena,
microcytic
anemia
20 days after treatment
for primary lung cancer
4th part of
duodenum
Large cell carcinoma Duodenectomy followed by
chemotherapy
12 months Dead
Brain metastasis
[8] 61/M Melena, weight
loss, hemoptysis
At time of diagnosis of
primary lung cancer
4th part of
duodenum
Adenocarcinoma Endoscopic resection,
Chemotherapy
Blood transfusion,
Erythropoietin
7 months Dead
Progressive lung
disease
[9] 55/M Upper GI
bleeding
– 3rd part of
duodenum
invading SMA
Adenocarcinoma – Few days Dead
Massive GI
bleeding
[10] 66/M Upper GI
bleeding
8 months after treatment
for primary lung cancer
– Adenocarcinoma – Few weeks Dead with
massive GI
bleeding
[11] 65/M Jaundice,
obstruction
– 2nd part of
duodenum
Squamous cell carcinoma Endoscopic resection – –
[13] 54/M Dysphagia During chemoradiation
for primary lung cancer
1st and 2nd parts
of duodenum
Squamous cell carcinoma Endoscopic resection 2 months Dead
[15] 69/M Incidental on
imaging
36 months after
treatment for primary
lung cancer
2nd part of
duodenum
Small cell carcinoma Palliative RT 30Gy in 10
fractions
– –
M=male, F = female, SMA= superior mesenteric artery, GI = gastrointestinal, RT = radiation therapy
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Fig. 4. (A) axial view of computed tomography chest showing left hilar mass encasing the left main pulmonary artery and causing narrowing of left upper lobe bronchus,
and (B) CT-PET imaging showing 18FDG avid left upper lobe elongated lung mass (standardized uptake volume 9.3) extending from the left hilum to the pleural surface in
the left apical region.
pancreatico-duodenectomy for symptomatic relief [6–10]. Endo-
scopic resection of smaller duodenal metastatic lesions (≤1 cm)
appears to be safe and effective, especially in cases in which these
metastases may be removed completely by endoscopic methods,
as seen in our patient [11–15]. The role of radiation therapy needs
to be investigated, as only case report utilizing radiation therapy
for duodenal metastasis has been reported [16].
Duodenalmetastasis is associatedwith dismal prognosis. Only a
few cases have survived more than 12 months after surgical resec-
tion of duodenalmetastases, with the exception of one patientwho
survived 46 months [9].
In conclusion, duodenal metastasis from lung adenocarcinoma
is extremely rare entity and should also be included in the differ-
ential diagnosis of melena. Smaller lesions (≤1 cm) can safely be
managed with endoscopic resection.
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